Rhode Island House Bill 7187: Prohibits healthcare insurers from requiring or conducting a review for prescription medicine used to treat alcohol or opioid use disorder containing Methadone, Burenorphine, or Naltrexone, or approved to mitigate opioid withdrawal symptoms.

Rhode Island · 2026 session

What it does

INSURANCE -- BENEFIT DETERMINATION AND UTILIZATION REVIEW ACT - Prohibits healthcare insurers from requiring or conducting a review for prescription medicine used to treat alcohol or opioid use disorder containing Methadone, Burenorphine, or Naltrexone, or approved to mitigate opioid withdrawal symptoms.

Latest action

Committee recommended measure be held for further study (2026-02-03)

See how H 7187 affects you on CapitolKey

Browse more bills · CapitolKey home